Mepolizumab is a humanized monoclonal antibody that neutralizes interleukin-5 (IL-5). It is a key research tool for investigating severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA), supporting both in vitro mechanistic studies and in vivo preclinical models of eosinophil-driven diseases.
Konzentration:
101.3 mg/mL
Molekulargewicht:
146.24 kDa
Reinheit:
98.00% (May vary between batches)
CAS Nummer:
[196078-29-2]
Target-Kategorie:
IL Receptor,Interleukin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten